Hospital
Raritan Bay Medical Center
Raritan Bay Medical Center was paid $8.36M by Medicaid between Jan 2018 and Aug 2018, across 217 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.
33Billing provider infoRARITAN BAY MEDICAL CENTER
PERTH AMBOY, NJ 08861
PERTH AMBOY, NJ 08861
33aNPI1770569832assigned 12/21/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.36M
24GClaims105,516
24DCodes billed217
24AFirst – last monthJan 2018 – Aug 2018
Compared with peers
Next to other General Acute Care Hospital providers in New Jersey
Rank by total paid#62 of 93
Median peer was paid$30.60M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 105,516 | $8.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 5,375 | 5,185 | $1.97M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 5,254 | 4,856 | $1.52M |
| G0378 | Hospital observation service, per hour | 13% | 1,575 | 1,260 | $1.07M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.6% | 1,322 | 1,249 | $465K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.4% | 1,409 | 1,371 | $286K |
| S9480 | Intensive outpatient psychiatric services, per diem | 3.1% | 325 | 310 | $260K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 2,500 | 602 | $206K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 2.3% | 363 | 357 | $193K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.5% | 117 | 117 | $129K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1.5% | 120 | 120 | $129K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.5% | 1,916 | 492 | $125K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.4% | 835 | 835 | $117K |
205 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 958 | $91K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 960 | $74K |
| 97010 | <1% | 2,251 | $71K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 423 | $62K |
| 97014 | <1% | 1,553 | $61K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 483 | $52K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 217 | $50K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 841 | $48K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 450 | $48K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,029 | $47K |
| 76830 | Ultrasound, transvaginal | <1% | 391 | $45K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 278 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,964 | $41K |
| 93017 | <1% | 176 | $37K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 422 | $37K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,327 | $36K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 253 | $35K |
| 80053 | Comprehensive metabolic panel | <1% | 5,003 | $33K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 146 | $31K |
| 76642 | <1% | 252 | $29K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 550 | $29K |
| 93970 | <1% | 89 | $27K | |
| OP250 | <1% | 3,599 | $26K | |
| 76801 | <1% | 221 | $23K | |
| 77080 | <1% | 172 | $23K | |
| 58558 | <1% | 15 | $22K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 192 | $21K |
| 77065 | Tomosynthesis, mammo | <1% | 164 | $20K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 739 | $19K |
| A0425 | Ground mileage, per statute mile | <1% | 439 | $19K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 171 | $19K |
| 76813 | <1% | 191 | $18K | |
| 72110 | <1% | 369 | $18K | |
| 93971 | <1% | 151 | $17K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 80 | $16K |
| 76536 | <1% | 124 | $16K | |
| 97161 | <1% | 286 | $16K | |
| 73564 | <1% | 381 | $15K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 366 | $15K |
| S9484 | Crisis intervention mental health services, per hour | <1% | 13 | $15K |
| 71045 | Radiologic examination, chest; single view | <1% | 989 | $14K |
| 82962 | <1% | 1,541 | $13K | |
| 76820 | <1% | 192 | $12K | |
| 84484 | <1% | 1,740 | $11K | |
| OP270 | <1% | 1,704 | $11K | |
| 76770 | <1% | 122 | $11K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 241 | $10K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 178 | $10K |
| 73630 | <1% | 385 | $10K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 416 | $10K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 984 | $10K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 128 | $10K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 344 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 763 | $10K |
| 72052 | <1% | 116 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,476 | $10K |
| 81001 | <1% | 3,282 | $10K | |
| 73030 | <1% | 304 | $9K | |
| J3490 | Unclassified drugs | <1% | 1,173 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 566 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 859 | $9K |
| 97035 | <1% | 222 | $8K | |
| 85610 | <1% | 1,207 | $8K | |
| 95886 | <1% | 42 | $7K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,201 | $7K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 416 | $7K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 101 | $7K |
| 85730 | <1% | 994 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,557 | $7K |
| 95911 | <1% | 21 | $6K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $6K |
| 70486 | <1% | 33 | $6K | |
| 80061 | Lipid panel | <1% | 505 | $6K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 147 | $6K |
| 97116 | <1% | 176 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 482 | $6K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 77 | $6K |
| 97162 | <1% | 128 | $6K | |
| 73130 | <1% | 261 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 170 | $5K |
| OP710 | <1% | 443 | $5K | |
| J2704 | Injection, propofol, 10 mg | <1% | 448 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 321 | $5K |
| 77066 | Tomosynthesis, mammo | <1% | 28 | $4K |
| 87040 | <1% | 593 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 251 | $4K |
| OP258 | <1% | 599 | $4K | |
| 83880 | <1% | 447 | $4K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 759 | $4K |
| 83735 | <1% | 769 | $4K | |
| 73110 | <1% | 203 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,252 | $4K |
| 84439 | <1% | 314 | $4K | |
| 82550 | <1% | 387 | $4K | |
| 74018 | <1% | 217 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 388 | $4K |
| 73610 | <1% | 313 | $4K | |
| 93226 | <1% | 54 | $3K | |
| 82553 | <1% | 286 | $3K | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 33 | $3K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 48 | $3K |
| 85027 | <1% | 681 | $3K | |
| 73502 | <1% | 118 | $3K | |
| OP278 | <1% | 37 | $3K | |
| 83605 | <1% | 272 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 61 | $3K |
| 83690 | <1% | 1,627 | $3K | |
| OP272 | <1% | 607 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 139 | $3K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 229 | $3K |
| 82607 | <1% | 183 | $3K | |
| 93880 | <1% | 54 | $3K | |
| 88342 | <1% | 164 | $3K | |
| 86850 | <1% | 438 | $3K | |
| 86901 | <1% | 441 | $2K | |
| 86900 | <1% | 442 | $2K | |
| OP370 | <1% | 444 | $2K | |
| 72081 | <1% | 38 | $2K | |
| 97032 | <1% | 85 | $2K | |
| 93225 | <1% | 55 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 734 | $2K |
| 87400 | <1% | 1,214 | $2K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 391 | $2K |
| 36430 | <1% | 23 | $2K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 57 | $2K |
| 72070 | <1% | 41 | $2K | |
| 85651 | <1% | 205 | $1K | |
| 86738 | <1% | 73 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 142 | $1K |
| 73140 | <1% | 131 | $1K | |
| 73080 | <1% | 94 | $1K | |
| J1245 | Injection, dipyridamole, per 10 mg | <1% | 36 | $1K |
| C1769 | Guide wire | <1% | 25 | $1K |
| 84702 | <1% | 350 | $1K | |
| 88304 | <1% | 120 | $1K | |
| 84163 | <1% | 49 | $1K | |
| 84132 | <1% | 24 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 22 | $1K |
| 81025 | <1% | 285 | $1K | |
| 82397 | <1% | 49 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 93 | $909.60 |
| 74019 | <1% | 115 | $901.27 | |
| J1815 | Injection, insulin, per 5 units | <1% | 114 | $848.12 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 93 | $846.32 |
| 80320 | <1% | 596 | $831.21 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 157 | $821.66 |
| 82728 | <1% | 33 | $805.10 | |
| 82746 | <1% | 32 | $798.59 | |
| 83550 | <1% | 37 | $765.22 | |
| 83615 | <1% | 41 | $760.01 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 84 | $749.66 |
| 82800 | <1% | 66 | $731.74 | |
| 82803 | <1% | 27 | $726.50 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 38 | $725.87 |
| 74021 | <1% | 109 | $720.20 | |
| 83540 | <1% | 37 | $707.27 | |
| 71100 | <1% | 45 | $693.40 | |
| 86140 | <1% | 68 | $671.24 | |
| 82248 | <1% | 77 | $640.51 | |
| 81003 | <1% | 277 | $610.76 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 184 | $609.59 |
| 86920 | <1% | 20 | $596.17 | |
| 90715 | <1% | 158 | $583.87 | |
| 73590 | <1% | 32 | $564.81 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 741 | $552.74 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 13 | $552.10 |
| 84480 | <1% | 60 | $533.18 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 206 | $379.68 |
| 83930 | <1% | 15 | $367.22 | |
| 82010 | <1% | 112 | $349.51 | |
| 84100 | <1% | 272 | $344.37 | |
| 82150 | <1% | 261 | $333.59 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 249 | $319.56 |
| 70360 | <1% | 12 | $302.22 | |
| 97166 | <1% | 12 | $300.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 150 | $247.39 |
| 82570 | <1% | 60 | $247.22 | |
| 73090 | <1% | 44 | $234.82 | |
| L1930 | Ankle foot orthosis, plastic or other material, prefabricated, includes fitting and adjustment | <1% | 45 | $220.00 |
| 72050 | <1% | 32 | $214.79 | |
| 84550 | <1% | 44 | $196.95 | |
| G0008 | Administration of influenza virus vaccine | <1% | 31 | $181.56 |
| 85379 | <1% | 230 | $171.34 | |
| 82247 | <1% | 23 | $166.89 | |
| 12001 | <1% | 14 | $161.27 | |
| 87420 | <1% | 206 | $146.16 | |
| 80329 | <1% | 96 | $145.04 | |
| 80076 | <1% | 30 | $101.65 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 30 | $94.22 |
| 96376 | <1% | 44 | $85.93 | |
| 87070 | <1% | 53 | $75.86 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 58 | $67.56 |
| 82565 | <1% | 25 | $62.39 | |
| 90656 | <1% | 12 | $61.86 | |
| 82043 | <1% | 14 | $56.64 | |
| 87449 | <1% | 12 | $48.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 241 | $44.81 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 31 | $29.73 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 17 | $8.00 |
| J0280 | Injection, aminophyllin, up to 250 mg | <1% | 15 | $7.00 |
| 36600 | <1% | 12 | $6.42 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 19 | $2.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 20 | $2.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialD'AGNES, MICHAEL (PRESIDENT CEO)